Examkin

Question

Difficulty: MediumHematology and Oncology

A 4646-year-old woman is hospitalized for induction chemotherapy for newly diagnosed acute myeloid leukemia. On hospital day 1212, she develops a new-onset fever. She reports feeling chilled and fatigued but has no cough, dysuria, abdominal pain, or skin changes. Her temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure is 105/65 mm Hg105/65\text{ mm Hg}, pulse is 115/min115/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination is unremarkable, with clear lungs and no induration around her central venous catheter. Laboratory studies reveal an absolute neutrophil count of 120/μL120/\mu\text{L}.

Arrange the following steps in the most appropriate chronological sequence for the management of this patient's complication.

  1. 1Obtain multiple sets of blood cultures and perform a careful physical examination to identify potential infectious sources.
  2. 2Initiate empiric intravenous broad-spectrum antibiotic therapy with antipseudomonal coverage (e.g., cefepime).
  3. 3Reassess the patient's clinical status and review preliminary microbiological culture data at 48 to 72 hours.
  4. 4Tailor the antimicrobial regimen based on identified pathogen susceptibilities or continue empiric therapy if cultures are sterile.
  5. 5Add empiric antifungal therapy if the patient remains persistently febrile and profoundly neutropenic after 4 to 7 days.

Answer

The correct chronological sequence is: 1) Obtain blood cultures and perform an exam, 2) Initiate empiric antipseudomonal antibiotics, 3) Reassess clinical status at 48-72 hours, 4) Tailor the antimicrobial regimen based on cultures, and 5) Add empiric antifungal therapy if fever persists for 4-7 days.
The standard of care for febrile neutropenia follows a strict algorithmic timeline. Immediate cultures are required to isolate pathogens before they are suppressed by medications. Because neutropenic patients can rapidly decompensate from bacterial sepsis (especially from Pseudomonas), empiric broad-spectrum antibiotics are given immediately after cultures. At 48-72 hours, initial culture results dictate whether to narrow or maintain the antibiotic regimen. Finally, if the patient remains febrile after 4-7 days of appropriate antibacterial therapy, occult fungal infections become a major concern, prompting the addition of empiric antifungals.

Step-by-Step Solution

1
Identify the clinical emergency.
The patient has a fever (38.9∘C38.9^\circ\text{C}) and severe neutropenia (ANC < 500/μL500/\mu\text{L}), establishing the diagnosis of febrile neutropenia.
Febrile neutropenia is an oncologic emergency requiring algorithmic, rapid intervention to prevent life-threatening sepsis.
2
Determine the immediate first action.
Blood cultures must be obtained prior to any drug administration.
Administering antibiotics before drawing cultures can sterilize the blood samples, preventing the identification of the causative organism.
3
Select the initial therapeutic intervention.
Empiric antipseudomonal antibiotics (e.g., cefepime) are administered immediately after cultures are drawn.
Gram-negative bacteremia, particularly from Pseudomonas aeruginosa, can rapidly cause septic shock in neutropenic hosts.
4
Establish the short-term follow-up plan.
Reassess the patient and review cultures at 48 to 72 hours, adjusting antibiotics based on susceptibilities.
This timeframe allows the initial empiric therapy to take clinical effect and provides sufficient time for microbiology labs to identify any isolated bacteria.
5
Determine the management for prolonged, refractory cases.
Add empiric antifungal therapy if fever persists beyond 4 to 7 days of appropriate antibacterial coverage.
Prolonged neutropenia with persistent fever despite broad-spectrum antibacterial therapy is highly suspicious for occult invasive fungal infections.

Key Concept

The management of febrile neutropenia requires immediate blood cultures followed by the rapid initiation of empiric antipseudomonal antibiotics; therapy is tailored at 48-72 hours, and antifungal coverage is added if fever persists beyond 4-7 days.
Estimated Time:1m 30s
Rate this question

Topics

Hematology and Oncology

More questions from this topic